A 52-year-old man who was prescribed indapamide [60], another Na-Cl symporter inhibitor, developed hypokalemia, hypocalcemia, hyponatremia, and other imbalances, leading to seizures and AKI. Here, SLC12A3 is linked to Hypocalcemia.